Novartis Ag (NVS) Retained Earnings (2009 - 2026)

Novartis Ag has disclosed Retained Earnings across 18 years of filings, most recently posting $40.9 billion for Q2 2026.

• In Q2 2026, Retained Earnings fell 0.96% year-over-year to $40.9 billion; the TTM figure through Jun 2026 stood at $40.9 billion (down 0.96% YoY), while the FY2025 annual figure was $45.4 billion, up 4.87% from the prior year.
• Retained Earnings came in at $40.9 billion for Q2 2026 at Novartis Ag, up from $37.8 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $62.1 billion in Q2 2022 to a low of $37.4 billion in Q3 2023.
• Average Retained Earnings over 5 years is $46.6 billion, with a median of $43.5 billion recorded in 2024.
• Year-over-year, Retained Earnings advanced 22.2% in 2022 and plunged 37.71% in 2023.
• Over 5 years, Retained Earnings stood at $58.5 billion in 2022, then dropped by 21.63% to $45.9 billion in 2023, then dropped by 5.62% to $43.3 billion in 2024, then grew by 4.87% to $45.4 billion in 2025, then decreased by 10.04% to $40.9 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $40.9 billion in Q2 2026, $37.8 billion in Q1 2026, and $45.4 billion in Q4 2025.